Stories

Discover all of the trending stories of Ipsen Group.

Key highlights

Explore more by category

Filter

Period

Filter by

recent search

Showing: 15 of 22 stories

Rhonda’s story: Writing her way through metastatic pancreatic cancer
 –  – 3 mins read

 – 3 mins read

Rhonda’s story: Writing her way through metastatic pancreatic cancer

Rhonda is a blogger on a mission. As an avid writer and reader, she’s maintained her personal blog for close to a decade. But in 2021, her writing took on a more meaningful purpose after she was diagnosed with pancreatic cancer.


Pharmacists: More than the “last step” on the care journey
 –  – 3 mins read

 – 3 mins read

Pharmacists: More than the “last step” on the care journey

Nisreen Shamseddine, PharmD, MS, MBA, a community pharmacist and currently a Medical Strategy Lead at Ipsen, shares why a pharmacist can be an important member of your care team and not only the “last step” before starting a new medicine.


Caitlin chose hope: Her dad’s experience with pancreatic cancer
 –  – 3 mins read

 – 3 mins read

Caitlin chose hope: Her dad’s experience with pancreatic cancer

When she first heard the prognosis, Caitlin thought, “that is not possible. My dad has to be at my graduation in May – he needs more time than that.” She knew that her family would fight for more time.


5 Ways Ipsen Keeps Compliance at Our Core
 –  – 3 mins read

 – 3 mins read

5 Ways Ipsen Keeps Compliance at Our Core

It’s no secret that the biotech and pharma industries are highly regulated and for very good reason. We have an important role to play in ensuring new, innovative medicines reach the people who need them. But the rules that govern…


Better, Bolder Science: Across the bench collaboration in epigenetics
 –  – 3 mins read

 – 3 mins read

Better, Bolder Science: Across the bench collaboration in epigenetics

Dr. Lindsey Rodrigues, a biomedical engineer and cancer biologist by training, and Lindsey Eichinger, who has a background in veterinary sciences and cell biology, are two scientists at Ipsen leading the exploration of epigenetics – a new frontier for cancer research and the future of cancer.